Predictors of service use of patients with co-morbid mental health and substance use disorders across seven European sites

References

• Anderson, J. F., & Warren, L. D. (2004). Client retention in the British Columbia Methadone Program. 1996–1999. Canadian Journal of Public Health, 95(2), 104–109.
   PubMed Web of Science ®Google Scholar
• Arfken, C. L., Klein, C., di Menza, S., Schuster, C. R. (2001). Gender differences in problem severity at assessment and treatment retention. Journal of Substance Abuse Treatment, 20(1), 53–57. doi: 10.1016/S0740-5472(00)00155-0
   PubMed Web of Science ®Google Scholar
• Baldacchino, A., & Corkery, J. (2006). Comorbidity research in Europe. Perspectives across Europe. London: European Collaborating Centre in Addiction Studies (ECCAS).
   Google Scholar
• Baldacchino, A., Greacen, T., Hodges, C.-L., Sieroslavrska, K., Sorsa, M., Groussard-Escaffre, N., …Baeck-Moller, K. (2010). Epidemiological problems in comorbidity: A European perspective. Journal of Mental Health and Substance Misuse: Dual Diagnosis, 2(2), 88–100. doi: 10.1080/17523280902930130
   Google Scholar
• Baldacchino, A., Greacen, T., Hodges, C.-L., Sieroslavrska, K., Sorsa, M., Groussard-Escaffre, N., …Baeck-Moller, K. (2011). Nature, level and type of networking for individuals with dual diagnosis: A European perspective. Drugs Education, Prevention and Policy, 18(5), 393–401. doi: 10.3109/09687637.2010.520171
   Web of Science ®Google Scholar
• Batel, P. (2000). Addiction and schizophrenia. European Psychiatry, 15(2), 115–122. doi: 10.1016/S0924-9338(00)00203-0
   PubMed Web of Science ®Google Scholar
• Bellack, A. S., & Gearon, J. S. (1998). Substance abuse treatment for people with schizophrenia. Addictive Behaviour, 23, 749–766. doi: 10.1016/S0306-4603(98)00066-5
   PubMed Web of Science ®Google Scholar
• Bottlender, M., & Soyka, M. (2005). Efficacy of an intensive outpatient rehabilitation program in alcoholism: Predictors of outcome 6 months after treatment. European Addiction Research, 11(3), 132–137. doi: 10.1159/000085548
   PubMed Web of Science ®Google Scholar
• Broome, K. M., Flynn, P. M., & Simpson, D. D. (1999). Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Service Research, 34, 791–806.
   PubMed Web of Science ®Google Scholar
• Bucci, S., Baker, A., Halpin, S. A., Baker, A., Halpin, S. A., Hides, L., … Startup, M. (2010). Intervention for cannabis use in young people at ultra high risk for psychosis and in early psychosis. Mental Health and Substance Use: Dual Diagnosis, 3, 66–73. doi: 10.1080/17523280903523983
   Google Scholar
• Carroll, K. M., Power, M. E., Bryant, K., & Rounsaville, B. J. (1993). One-year follow-up status of treatment seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome. Journal of Nervous and Mental Disease, 181, 71–79. doi: 10.1097/00005053-199302000-00001
   PubMed Web of Science ®Google Scholar
• Case, N. (1991). The dual-diagnosis patient in a psychiatric day treatment program: a treatment failure. Journal of Substance Abuse Treatment, 8, 69–73. doi: 10.1016/0740-5472(91)90029-A
   PubMed Web of Science ®Google Scholar
• Chen, S., Barnett, P. G., Sempel, J. M., & Timko, C. (2006). Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients’ symptom severity. Journal of Substance Abuse Treatment, 31, 95–105. doi: 10.1016/j.jsat.2006.03.015
   PubMed Web of Science ®Google Scholar
• Department of Health. (2002). Mental health policy implementation guide. Dual diagnosis good practice guide. London: Author.
   Google Scholar
• Derogatis, L. R., & Cleary, P. A. (1997). Factorial invariance across gender for the primary symptom dimension of the SCL-90. British Journal of Social and Clinical Psychology, 16, 347–356. doi: 10.1111/j.2044-8260.1977.tb00241.x
   Google Scholar
• Derogatis, L. R., Lipman, R. S., & Covi, L. (1973). SCL-90: An outpatient psychiatric rating scale – preliminary report. Psychopharmacology Bulletin, 9, 13–28.
   PubMedGoogle Scholar
• Dilonardo, J., Coffey, R., Vandivort-Warren, R., & Buck, J. (2008). Inpatient utilization for persons with co-occurring disorders. Psychiatric Services, 59(1), 14. doi: 10.1176/appi.ps.59.1.14
   PubMed Web of Science ®Google Scholar
• Dixon, L. (1999). Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophrenia Research, 35, S93–S100. doi: 10.1016/S0920-9964(98)00161-3
   PubMed Web of Science ®Google Scholar
• Drake, R. E., Mercer-McFadden, C., Mueser, K. T., McHuge, G. J., & Bond, G. R. (1998). Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin, 24, 589–608. doi: 10.1093/oxfordjournals.schbul.a033351
   PubMed Web of Science ®Google Scholar
• Drake, R. E., Mueser, K. T., Clark, R. E., & Wallach, M. A. (1996). The course, treatment and outcome of substance disorder in persons with severe mental illness. American Journal Orthopsychiatry, 66, 42–51. doi: 10.1037/h0080153
   PubMed Web of Science ®Google Scholar
• Drake, R. E., O'Neal, E., & Wallach, M. A. (2008). A systematic review of research on interventions for people with co-occuring severe mental and substance use disorders. Journal of Substance Abuse Treatment, 34, 123–138. doi: 10.1016/j.jsat.2007.01.011
   PubMed Web of Science ®Google Scholar
• Elbogen, E. B., Swanson, J. W., Swartz, M. S., & Van Dorn, R. (2005). Medication non adherence and substance abuse in psychotic disorders: Impact of depressive symptoms and social stability. Journal of Nervous and Mental Disease, 93(10), 673–679. doi: 10.1097/01.nmd.0000180742.51075.70
   Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2004). Comorbidity – drug use and mental disorders. Drugs in Focus 14. Retrieved from http://www.emcdda.europa.eu/attachments.cfm/att_44768_EN_Dif14EN.pdf
   Google Scholar
• Gandek, B., Ware, J. E. Jr., Aaronson, N. K., Apolone, G., Bjorner, J. B., & Brazier, J. E. (1998). Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: Results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology, 51, 1149–1158.
   PubMed Web of Science ®Google Scholar
• Granholm, E., Anthenelli, R., Monteiro, R., Sevcik, J., & Stoler, M. (2003). Brief integrated outpatient dual diagnosis treatment reduces psychiatric hospitalizations. American Journal on Addictions, 12(4), 306–313.
   PubMed Web of Science ®Google Scholar
• Greacen, T., Baldacchino, A., Sieroslavska, K., Sorsa, M., Groussard-Escaffre, N., Clancy, C., … Baeck-Moller, K. (2011). Pathways through care for people with dual diagnosis in Europe: Results from the treatment options for dual diagnosis (TODD) user zoom instrument. Mental Health and Substance Use: Dual Diagnosis, 4(3), 195–210. doi: 10.1080/17523281.2011.578281
   Google Scholar
• Green, C.A., Polen, M. R., Dickinson, D. M., Lynch, F. L., & Bennett, M. D. (2002). Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program. Journal of Substance Abuse Treatment, 23, 285–295. doi: 10.1016/S0740-5472(02)00278-7
   PubMed Web of Science ®Google Scholar
• Grella, C. E., & Gilmore, J. (2002). Improving service delivery to the dually diagnosed in Los Angeles County. Journal of Substance Abuse Treatment, 23, 115–122. doi: 10.1016/S0740-5472(02)00254-4
   PubMed Web of Science ®Google Scholar
• Guitton, J., David, O., Mialon, A., & Manchon, M. (1993). Evaluation of an automated liquid chromatograph permitting toxicologic screening of biological fluids. Annals of Clinical Biology, 51, 611–617.
   PubMed Web of Science ®Google Scholar
• Haller, D. L., & Miles, D. R. (2004). Psychopathology is associated with completion of residential treatment in drug dependent women. Journal of Addictive Diseases, 23, 17–28. doi: 10.1300/J069v23n01_02
   PubMed Web of Science ®Google Scholar
• Hayes, R. A., Andrews, N., Baron-Jeffrey, M., Conley, C., Gridley, K., Norman, R., & Wright, G. (2003). Service enhancement to a dual-diagnosis population: Mental illness/substance abuse (MISA). Quality Management in Health Care, 12, 133–150. doi: 10.1097/00019514-200307000-00004
   PubMedGoogle Scholar
• Hellerstein, D. J., Rosenthal, R. N., & Miner, C. R. (2001). Integrating services for schizophrenia and substance abuse. Psychiatry Quarterly, 72(4), 291–306. doi: 10.1023/A:1010385114289
   PubMed Web of Science ®Google Scholar
• Herbeck, D. M., Fitek, D. J., Svikis, D. S., Montoya, I. D., Marcus, S. C., & West, J. C. (2005). Treatment compliance in patients with comorbid psychiatric and substance use disorders. American Journal on Addictions, 14, 195–207. doi: 10.1080/10550490590949488
   PubMed Web of Science ®Google Scholar
• Hodges, C. L., Patterson, S., Taikato, M., McGarrol, S., Crome, I., & Baldacchino, A. (2006). Comorbid mental health and substance misuse in Scotland. Edinburgh: Scottish Executive Substance Misuse Research.
   Google Scholar
• Kamal, F., Flavin, S., Campbell, F., Behan, C., Fagan, J., & Smyth, R. (2007). Factors affecting the outcome of methadone maintenance treatment dependence. Irish Medical Journal, 100, 393–397.
   PubMedGoogle Scholar
• King, A. C., & Canada, S. A. (2004). Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy. Journal of Substance Abuse Treatment, 26(3), 189–195. doi: 10.1016/S0740-5472(03)00210-1
   PubMed Web of Science ®Google Scholar
• Kofoed, L., Kania, J., Walsh, T., & Atkinson, R. M. (1986). Outpatient treatment of patients with substance abuse and coexisting psychiatric disorders. American Journal of Psychiatry, 143(7), 867–872.
   PubMed Web of Science ®Google Scholar
• Lecrubier, Y., Harnett-Sheehan, D. V., Weiller, E., Janavs, J., Weiller, E., Bonara, L. I., … Dunbar, G. (1997). The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. European Psychiatry, 12(5), 224–231. doi: 10.1016/S0924-9338(97)83296-8
   Web of Science ®Google Scholar
• Leonhard, C., Mulvey, K., Gastfriend, D. R., & Shwartz, M. (2000). The Addiction Severity Index – a field study of internal consistency and validity. Journal of Substance Abuse Treatment, 18(2), 129–135. doi: 10.1016/S0740-5472(99)00025-2
   PubMed Web of Science ®Google Scholar
• Lowe, A. L., & Abou-Saleh, M. T. (2004). The British experience of dual diagnosis in the National Health Service. Acta Neuropsychiatrica, 16, 41–46. doi: 10.1111/j.1601-5215.2004.0060.x
   PubMed Web of Science ®Google Scholar
• Maremmani, I., Pacini, M., Lubrano, S., Perugi, G., Tagliamonte, A., Pani, P. P., … Shinderman, M. (2008). Longterm outcomes of treatment-resistant heroin addicts with and without DSM-IV Axis psychiatric comorbidity (dual diagnosis). European Addiction Research, 14, 134–142. doi: 10.1159/000130417
   PubMed Web of Science ®Google Scholar
• McGovern, M. P., Matzkin, A. L., & Giard, J. (2007). Assessing the dual diagnosis capability of addiction treatment services: The dual diagnosis capability in addiction treatment DDCAT index. Journal of Dual Diagnosis, 3(2), 111–124. doi: 10.1300/J374v03n02_13
   Web of Science ®Google Scholar
• McHorney, C. A., Ware, J. E. Jr., & Raczek, A. E. (1993). The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31, 244–263. doi: 10.1097/00005650-199303000-00006
   Web of Science ®Google Scholar
• Mertens, J. R., & Weisner, C.M. (2000). Predictors of substance abuse treatment retention among women and men in an HMO. Alcoholism: Clinical and Experimental Research, 24, 1525–1533. doi: 10.1111/j.1530-0277.2000.tb04571.x
   PubMed Web of Science ®Google Scholar
• Moggi, F., Giovanoli, A., Buri, C., Moos, B. S., & Moos, R. S. (2010). Patients with substance use and personality disorders: A comparison of patient characteristics, treatment process, and outcomes in Swiss and U.S. substance use disorder programs. The American Journal of Drug and Alcohol Abuse, 36, 66–72. doi: 10.3109/00952990903575806
   PubMed Web of Science ®Google Scholar
• Moos, R. H., Nichol, A. C., Moos, B. S. (2002). Global assessment of functioning ratings and the allocation and outcomes of mental health services. Psychiatric Services, 53(6), 730–737. doi: 10.1176/appi.ps.53.6.730
   PubMed Web of Science ®Google Scholar
• Nilson, M., Fridell, M., & Griffiths, P. (2006). Definition and classification in comorbidity. In J. Corkery & A. Baldacchino (Eds.), European Collaborating Centres on Addiction Studies (ECCAS) Monograph series 4: Co-morbidity: Perspectives across Europe (pp. 351–363). London: ECCAS.
   Google Scholar
• Öjehagen, A., & Schaar, I. (2003). Mentally ill substance abusers in Sweden: A 5-year follow-up of a multisite study of co-operation between psychiatric services and social authorities. In G. Carrà & M. Clerici (Eds.), Dual diagnosis: Filling the gap (pp. 49–54). Paris: John Libbey.
   Google Scholar
• Ouimette, P., Jemelka, R., Hall, J., Brimner, K., Krupski, A., & Stark, K. (2007). Services to patients with dual diagnoses: Findings from Washington's mental health service system. Substance Use and Misuse, 42(1), 113–127. doi: 10.1080/10826080601096657
   PubMed Web of Science ®Google Scholar
• Owen, R. R., Fischer, E. P., Booth, B. M., & Cuffel, B. J. (1997). Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services, 47, 853–858.
   Web of Science ®Google Scholar
• Primm, A. B., Gomez, M. B., Tzolova-Iontchev, I., Perry, W., Vu, H. T., & Crum, R. M. (2000). Severely mentally ill patients with and without substance use disorders: Characteristics associated with treatment attrition. Journal of Community Mental Health, 36(3), 235–246. doi: 10.1023/A:1001953030073
   Google Scholar
• Ridgely, M. S., Lambert, D., Goodman, A., Chichester, C. S., & Ralph, R. (1998). Interagency collaboration in services for people with co-occurring mental illness and substance use disorder. Psychiatric Services, 49(2), 236–238.
   PubMed Web of Science ®Google Scholar
• Rosenheck, R., Gallup, P., Frisman, L. K. (1993). Health care utilization and costs after entry into an outreach program for homeless mentally ill veterans. Hospital and Community Psychiatry, 44, 1166–1171.
   PubMedGoogle Scholar
• Rosenblum, A., Fallon, B., Magura, S., Handelsman, L., Foote, J., & Bernstein, D. (1999). The autonomy of mood disorders among cocaine-using methadone patients. American Journal of Drug and Alcohol Abuse, 25, 67–80. doi: 10.1081/ADA-100101846
   PubMed Web of Science ®Google Scholar
• Ross, H. E., Cutler, M., & Sklar, S. M. (1997). Retention in substance abuse treatment. Role of psychiatric symptom severity. American Journal on Addictions, 6, 293–303.
   PubMed Web of Science ®Google Scholar
• Salloum, I. M., Moss, H. B., & Daley, D. C. (1991). Substance abuse and schizophrenia impediments to optimal care. American Journal on Drug and Alcohol Abuse, 17, 321–336. doi: 10.3109/00952999109027556
   PubMed Web of Science ®Google Scholar
• Saxon, A. J., & Calsyn, D. A. (1995). Effects of psychiatric care for dual diagnosis patients treated in a drug dependence clinic. American Journal of Drug and Alcohol Abuse, 21, 303–313. doi: 10.3109/00952999509002699
   PubMed Web of Science ®Google Scholar
• Sayre, S. L., Schmitz, J. M., Stotts, A. L., Averill, P. M., Rhoades, H. M., & Grabowski, J. J. (2002). Determining predictors of attrition in an outpatient substance abuse program. American Journal of Drug and Alcohol Abuse, 28(1), 55–72. doi: 10.1081/ADA-120001281
   PubMed Web of Science ®Google Scholar
• Schafer, I., Fischer, M., Reimer, J., Karow, A., & Haasen, C. (2011). Significance of psychiatric comorbidity for the outcome of maintenance treatment-a review of the literature. Mental Health and Substance Use, 4(1), 62–71. doi: 10.1080/17523281.2011.533452
   Google Scholar
• Sheehan, D. V., Lecrubier, Y., Harnett-Sheenan, K., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., & Dunbar, G. (1998). The Mini International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59, 22–33.
   PubMed Web of Science ®Google Scholar
• Simpson, D., Brathwaite, R., Jarvie, D., Stewart, M. J., Walker, S., Watson, I. W., & Widdop, B. (1987). Screening for drugs of abuse (II): Cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs. Annals of Clinical Biochemistry, 34, 460–510.
   Google Scholar
• Siqueland, L., Crits-Christoph, P., Gallop, R., Griffin, M. L., Thase, M. E., Daley, D., Frank, A., Gastfriend, D. R., Blaine, J., Connolly, M. B., & Gladis, L. (2002). Retention in psychosocial treatment of cocaine dependence: Predictors and impact on outcome. American Journal on Addictions, 11(1), 24–40. doi: 10.1080/10550490252801611
   PubMed Web of Science ®Google Scholar
• SPSS. (2006). SPSS 15.0 Command syntax reference. Chicago: Author.
   Google Scholar
• Staiger, P. K., Long, C., & Baker, A. (2010). Health service systems and comorbidity: Stepping up to the mark. Journal of Mental Health and Substance Use: Dual Diagnosis, 3, 148–161. doi: 10.1080/17523281003733514
   Google Scholar
• Swofford, C. D., Kaschow, J. W., Scheller-Gilkey, G., & Ibderbitzin, L. B. (1996). Substance use: A powerful predictor of relapse in schizophrenia. Schizophrenia Research, 20, 145–151. doi: 10.1016/0920-9964(95)00068-2
   PubMed Web of Science ®Google Scholar
• Trafton, J. A., Minkel, J., & Humphreys, K. (2006). Opioid substitution treatment reduces substance use equivalently in patients with and without posttraumatic stress disorder. Journal of Studies on Alcohol, 67, 228–235.
   PubMed Web of Science ®Google Scholar
• Tsuang, J. W., Fong, T. W., & Ho, A. P. (2003). Dual diagnosis and treatment compliance. Psychiatric Services, 54(4), 576. doi: 10.1176/appi.ps.54.4.576
   PubMed Web of Science ®Google Scholar
• Verdiun, M. L., Carter, R. E., Brady, K. T., Myrick, H., & Timmerman, M. A. (2005). Health service use among persons with comorbid bipolar and substance use disorders. Psychiatric Services, 56(4), 475–480. doi: 10.1176/appi.ps.56.4.475
   PubMed Web of Science ®Google Scholar
• Verdoux, H., Tournier, M., & Cougnard, A. (2005). Impact of substance use on the onset and course of early psychosis. Schizophrenia Research, 79, 69–75. doi: 10.1016/j.schres.2004.12.008
   PubMed Web of Science ®Google Scholar
• Verthein, U., Degkwitz, P., Haasen, C., & Krausz, M. (2005). Significance of comorbidity for the long-term course of opiate dependence. European Addiction Research, 11, 15–21. doi: 10.1159/000081412
   PubMed Web of Science ®Google Scholar
• Ware, J. E. Jr., Kosinski, M., & Gandek, B. (1998). The factor structure of the SF-36 Health Survey in 10 countries: Results from the IQOLA Project.International Quality of Life Assessment. Journal of Clinical Epidemiology, 51, 1159–1165. doi: 10.1016/S0895-4356(98)00107-3
   PubMed Web of Science ®Google Scholar
• Weaver, T., Renton, A., & Stimson, G. (1999). Severe mental illness and substance misuse. British Medical Journal, 319, 137–138. doi: 10.1136/bmj.318.7177.137
   PubMed Web of Science ®Google Scholar
• Westhuis, D. J., Gwaltney, L., & Hayashi, R. (2001). Outpatient cocaine abuse treatment: Predictors of success. Journal of Drug Education, 31(2), 171–183. doi: 10.2190/DQ7G-NBXR-6YQ7-1RXJ
   PubMedGoogle Scholar
• World Health Organization. (1992). International classification of diseases, 10th edition (ICD-10). Geneva: Author.
   Google Scholar
• World Health Organization. (2005). Mental Health Action Plan for Europe: Facing the challenges, building solutions. Retrieved from http://euro.who.int/Document/MNH/edoc07.pdf
   Google Scholar
• Xie, H., McHugo, G. J., & Drake, R. E. (2009). Subtypes of clients with serious mental illness and co-occurring disorders: Latent-class trajectory analysis. Psychiatric Services, 60(6), 804–811. doi: 10.1176/appi.ps.60.6.804
   PubMedGoogle Scholar
• Zanis, D. A., McLellan, A. T., & Corse, S. (1997). Is the Addiction Severity Index a reliable and valid assessment instrument among clients with severe and persistent mental illness and substance abuse disorders? Journal of Community Mental Health, 33, 213–227. doi: 10.1023/A:1025085310814
   Google Scholar
• Ziedonis, D. M., Smelson, D., Rosenthal, R. N., Batki, S. L., Green, A. I., Henry, R. J., … Weiss, R. D. (2005). Improving the care of individuals with schizophrenia and substance use disorders: Consensus recommendations. Journal of Psychiatric Practice, 11(5), 315–339. doi: 10.1097/00131746-200509000-00005
   PubMedGoogle Scholar